SEI Investments
BHVN

SEI Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

SEI Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,806
Closed -$4.66M – 2748
2022
Q3 		$4.66M Sell
30,806
-23,725
-44% -$3.52M 0.01% 1125
2022
Q2 		$7.95M Buy
54,531
+37,202
+215% +$4.75M 0.02% 872
2022
Q1 		$2.05M Buy
17,329
+2,914
+20% +$363K ﹤0.01% 1529
2021
Q4 		$1.99M Buy
14,415
+8,451
+142% +$1.07M ﹤0.01% 1586
2021
Q3 		$828K Sell
5,964
-6,513
-52% -$813K ﹤0.01% 1862
2021
Q2 		$1.22M Buy
12,477
+477
+4% +$38.7K ﹤0.01% 1731
2021
Q1 		$820K Buy
12,000
+3,605
+43% +$292K ﹤0.01% 1836
2020
Q4 		$720K Sell
8,395
-3,265
-28% -$277K ﹤0.01% 1823
2020
Q3 		$758K Buy
11,660
+6,920
+146% +$454K ﹤0.01% 1723
2020
Q2 		$347K Buy
+4,740
New +$252K ﹤0.01% 2020

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

SEI Investments's BHVN Position: Q4 2022 in Review

SEI Investments sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 30,806 shares — an estimated $4.66M sold.

SEI Investments first reported a position in BHVN in Q2 2020 and held it in 10 quarters. The position peaked at $7.95M in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • SEI Investments reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • SEI Investments sold 30,806 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $4.66M.
  • SEI Investments first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 10 quarters.
  • SEI Investments's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $7.95M in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.